Illinois Senator Lightford Passes Sweeping Hemp, Cannabis, CBD Bill

Legislative Framework and Scope

The Lightford bill consolidates regulatory authority over hemp-derived cannabinoids, adult-use cannabis, and CBD products under a unified compliance regime. On a strict reading of existing Illinois law, hemp products containing delta-8 THC, delta-10 THC, and other semi-synthetic cannabinoids fall outside the Cannabis Regulation and Tax Act (410 ILCS 705/) and the Industrial Hemp Act (505 ILCS 89/). This split has created enforcement gaps. Particularly troublesome: products sold in gas stations and convenience stores that contain psychoactive cannabinoids derived from hemp but marketed outside the state's licensed cannabis supply chain.

The legislation mandates that all cannabinoid products intended for human consumption—regardless of source plant—undergo laboratory testing for potency, pesticides, heavy metals, and microbial contaminants. Testing protocols mirror those currently enforced by the Illinois Department of Agriculture (IDOA) for adult-use cannabis. A 21-year minimum age now applies to any product containing more than 0.3% total THC, closing a loophole that's allowed minors to access delta-8 and similar compounds in unregulated retail settings.

Tax and Compliance Implications

Lightford's bill imposes a new excise tax on hemp-derived intoxicating cannabinoids at rates comparable to Illinois' adult-use cannabis tax structure. Products containing delta-8 THC, THC-O, or HHC would be taxed at 10% of gross receipts at the wholesale level, with an additional retail tax of up to 25% depending on THC concentration. This mirrors the tiered tax system in 410 ILCS 705/55-1, which currently applies only to cannabis sold through licensed dispensaries.

The tax provision addresses significant revenue leakage. Illinois collected $445.3 million in adult-use cannabis tax revenue in fiscal year 2025, according to the Illinois Department of Revenue, but an estimated $120 million in sales of hemp-derived intoxicants went untaxed. By bringing these products into the tax net, the state projects an additional $30-40 million in annual collections, earmarked for the Cannabis Regulation Fund and the Restore, Reinvest, and Renew (R3) Program established under the original legalization statute.

Operators face a substantial compliance burden. Retailers currently selling hemp-derived products will be required to obtain a Hemp Retailer License from IDOA and submit to quarterly audits. Manufacturers must register with the Department of Public Health and maintain batch-level traceability in the state's existing BioTrack THC seed-to-sale system. Failure to comply carries civil penalties of up to $10,000 per violation, with criminal liability for repeat offenders under 720 ILCS 550/ (the Cannabis Control Act).

Next Steps and Effective Date

The bill now advances to the full Illinois Senate for a floor vote, with an anticipated effective date of January 1, 2027, if signed into law. Senator Lightford chairs the Senate Revenue Committee, giving the legislation a strong procedural advantage. Industry groups representing hemp retailers have signaled opposition, though, arguing that the tax rates will render their products uncompetitive against illicit markets and licensed dispensaries that benefit from economies of scale.

IDOA will be tasked with promulgating emergency rules within 90 days of enactment, detailing licensing procedures, testing standards, and packaging requirements. The agency's existing cannabis regulatory framework under 8 Ill. Adm. Code 1000 will serve as the template, though IDOA has indicated it'll seek public comment on delta-8-specific testing thresholds and labeling disclosures. For a full legislative history and related bills, see the CannIntel topic hub on Illinois cannabis legislation.

The political calculus is straightforward. Licensed cannabis operators support the bill because it levels the playing field, while hemp retailers view it as a de facto prohibition through over-regulation. The outcome will hinge on whether the General Assembly prioritizes consumer safety and tax equity over concerns about small-business compliance costs.